Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosis.

Piggott, Thomas; Nonino, Francesco; Baldin, Elisa; Filippini, Graziella; Rijke, Nick; Schünemann, Holger; Laurson-Doube, Joanna

Piggott, Thomas; Nonino, Francesco; Baldin, Elisa; Filippini, Graziella; Rijke, Nick; Schünemann, Holger; Laurson-Doube, Joanna.

Afiliación

Piggott T; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Nonino F; Cochrane Multiple Sclerosis and Rare Diseases of the CNS Review Group, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Baldin E; Cochrane Multiple Sclerosis and Rare Diseases of the CNS Review Group, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Filippini G; Cochrane Multiple Sclerosis and Rare Diseases of the CNS Review Group, Scientific Director's Office, Carlo Besta Foundation and Neurological Institute, Milan, Italy.
Rijke N; Multiple Sclerosis International Federation, London, UK.
Schünemann H; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Laurson-Doube J; Multiple Sclerosis International Federation, London, UK.

Mult Scler J Exp Transl Clin ; 7(4): 20552173211051855, 2021 Oct.

Article en En | MEDLINE | ID: mdl-34900327

Palabras clave

Grading of Recommendations, Assessment, Development and Evaluations (GRADE); Multiple sclerosis; disease-modifying therapies; guideline methodology; off-label treatment; recommendations

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Aspecto: Equity_inequality Idioma: En Revista: Mult Scler J Exp Transl Clin Año: 2021 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google